Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

KCI Announces FDA Clearance Of ABThera™ Open Abdomen Dressing
Kinetic Concepts, Inc. (NYSE: KCI) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ABThera™ Open Abdomen Dressing. Earlier this year, the FDA cleared the ABThera™ Open Abdomen Negative Pressure Therapy Unit. Together, the ABThera™ Open Abdomen Negative Pressure Therapy System will be indicated for temporary bridging of abdominal wall openings where primary closure is not possible or repeat abdominal entries are necessary. The intended use of the system is for open abdominal wounds, with exposed viscera, including but not limited to abdominal compartment syndrome.

BMA Scotland GP Leader Calls On Scottish Government To Listen, Support And Work With GPs To Help Improve Patient Care
As GPs across the UK gathered in London for the Annual Conference of Local Medical Committees, Dr Dean Marshall, chairman of the BMA"s Scottish General Practitioners Committee, slammed the government for trying to strip GPs of funding and called for the profession to make decisions about general practice, not civil servants.
News of the day
PharmAthene Submits SparVax(TM) Regulatory Strategy To FDA
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced that the Company has submitted its comprehensive regulatory strategy to the U.S. Food and Drug Administration (FDA) outlining the non-clinical and clinical development plans for licensure of SparVax(TM), a next generation recombinant protective antigen anthrax vaccine.
Medical Devices

Government Of Canada Acts To Protect Newborns And Infants From Bisphenol A In Polycarbonate Plastic Baby Bottles

The Government of Canada is moving forward with proposed regulations to prohibit the advertisement, sale and importation of polycarbonate plastic baby bottles that contain bisphenol A, otherwise known as BPA, to reduce newborn and infant exposure to this substance, announced the Honourable Leona Aglukkaq, Minister of Health. BPA is used in the production of polycarbonate, a clear hard plastic used to make many products, including baby bottles. When in contact with hot or boiling liquid, bisphenol A can migrate from the plastic into the liquid and easily be ingested. "Our Government is acting to protect its most vulnerable citizens-newborns and infants," said Minister Aglukkaq. "Canada is the first country to move ahead with regulations to prohibit polycarbonate baby bottles that contain bisphenol A. We want parents to feel confident that they can safely bottle-feed their newborns and infants." The Government has concluded that exposure levels for newborns and infants up to 18 months of age are below those that could cause health effects. However, due to the uncertainty raised in some studies relating to the potential effects of low levels of BPA, the Government wants to further limit exposure. These actions are the latest measures by the Government of Canada to regulate chemicals that are harmful to human health or the environment under Canada"s world-leading Chemicals Management Plan. Health Canada has now published these proposed regulations in Canada Gazette Part I for a 75 day public comment period to consult with interested parties. Please visit the Chemical Substances website for more information on the Chemicals Management Plan. Health Canada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009